Pipeline Report 2023: Game on for blockbusters, novel MOAs and more

The industry awaits a number of readouts and approvals for drugs that address market gaps and enrich treatment landscapes — with huge sales potential to boot.

Related Keywords

Canada ,Australia ,Roshni Basu ,Astrazeneca Daiichi Sankyo ,Astrazeneca Soliris ,Alessandra Franceschetti ,Amanda Weyerbacher ,Eli Lilly Taltz ,Astrazeneca Fasenra ,Novo Nordisk Wegovy ,Abbvie Humira ,Novarti Cosentyx ,Eric Blouin ,Lavan Khandan ,Verona Pharma ,Bimekizumab Bimzelx ,Jasmine Lucas ,Sam Leach ,Eli Lilly ,Hannah Brown ,Sanofi Alnylam ,Ashley Ingles ,Lindsay Weisker ,Keytruda Merck ,Mamting Thoo ,Lindsey Sohl ,Sandra Teoh ,Elizabeth Machado ,Simone Gabriele ,Amgen ,Inthought Research ,Novartis ,Pfizer ,Drug Administration ,Astrazeneca ,Credit Suisse ,Novo Nordisk ,Inflation Reduction Act ,Adis Insight ,Leon Henderson Maclennan ,Aine Kyle ,Penny Robinson ,Daiichi Sankyo ,Initial Phase ,Respiratory System Lungs Anatomy ,Michelle Tan ,Bavarian Nordic ,